XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.4
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Series C Convertible Preferred Stock
IPO, Equity Line and Third Party
Preferred Stock
Series C Convertible Preferred Stock
Common Stock
Common Stock
IPO, Equity Line and Third Party
Additional Paid-in Capital
Additional Paid-in Capital
IPO, Equity Line and Third Party
Accumulated Deficit
Non Employee
Non Employee
Additional Paid-in Capital
Beginning Balance, Shares at Apr. 30, 2023       380,871 101,332            
Beginning Balance at Apr. 30, 2023 $ 230,557     $ 381 $ 101   $ 60,987,273   $ (60,757,198)    
Sale of Common Stock, net of fees, Shares           9,847          
Sale of Common Stock, net of fees     $ 671,894     $ 11   $ 671,883      
Common stock issued for consulting services, Shares         1,087            
Common stock issued for consulting services $ 100,000       $ 1   99,999        
Stock issued upon conversion, Shares 20 431   (431) 20            
Stock issued upon conversion       $ (1)     1        
Warrants issued to nonemployees $ 232,614           232,614        
Stock based compensation - management & other employees 230,486           230,486        
Net loss (3,115,233)               (3,115,233)    
Ending Balance, Shares at Oct. 31, 2023       380,440 112,286            
Ending Balance at Oct. 31, 2023 (1,649,682)     $ 380 $ 113   62,222,256   (63,872,431)    
Beginning Balance, Shares at Jul. 31, 2023       380,440 106,859            
Beginning Balance at Jul. 31, 2023 (519,702)     $ 380 $ 107   61,603,864   (62,124,053)    
Sale of Common Stock, net of fees, Shares           5,427          
Sale of Common Stock, net of fees     279,944     $ 6   279,938      
Warrants issued to nonemployees                   $ 232,614 $ 232,614
Stock based compensation - management & other employees 105,840           105,840        
Net loss (1,748,378)               (1,748,378)    
Ending Balance, Shares at Oct. 31, 2023       380,440 112,286            
Ending Balance at Oct. 31, 2023 (1,649,682)     $ 380 $ 113   62,222,256   (63,872,431)    
Beginning Balance, Shares at Apr. 30, 2024       380,440 676,598            
Beginning Balance at Apr. 30, 2024 $ 7,317,301     $ 380 $ 677   74,678,650   (67,362,406)    
Sale of Common Stock, net of fees, Shares 271,223       271,223 176,762          
Sale of Common Stock, net of fees     724,866     $ 177   724,689      
Common Stock issued resulting from Reverse Stock Split, Shares         94,461            
Common Stock issued resulting from Reverse Stock Split         $ 94   (94)        
Stock issued upon conversion, Shares         78,893            
Warrants issued to nonemployees $ 10,046           10,046        
Stock based compensation - management & other employees 99,115           99,115        
Net loss (4,134,607)               (4,134,607)    
Ending Balance, Shares at Oct. 31, 2024       380,440 947,821            
Ending Balance at Oct. 31, 2024 4,016,721     $ 380 $ 948   75,512,406   (71,497,013)    
Beginning Balance, Shares at Jul. 31, 2024       380,440 906,416            
Beginning Balance at Jul. 31, 2024 5,933,958     $ 380 $ 907   75,346,766   (69,414,095)    
Sale of Common Stock, net of fees, Shares           41,405          
Sale of Common Stock, net of fees     $ 121,120     $ 41   $ 121,079      
Stock based compensation - management & other employees 44,561           44,561        
Net loss (2,082,918)               (2,082,918)    
Ending Balance, Shares at Oct. 31, 2024       380,440 947,821            
Ending Balance at Oct. 31, 2024 $ 4,016,721     $ 380 $ 948   $ 75,512,406   $ (71,497,013)